Mix & measure TB-500 + BPC-157 5 mg Pre-filled with this protocols recommended BAC water and documented starting dose edit any field to run your own numbers
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
One clinical trial has tested the safety and efficacy of CB4211, a MOTS-c analogue, in the treatment of obese subjects with nonalcoholic fatty liver disease, where it was found to be effective at reducing body weight and liver fat content
That means you can easily get the care you need through our app when and where it works for you
Whats happening: Active gut-lining repair is underway
